Michelle Busch
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Viral Infectious Diseases and Gene Expression in Insects 1
- Protein Degradation and Inhibitors 1
- Oncology 5
- HER2/EGFR in Cancer Research 5
- Co-authors
- Diego A. Gianolio (7 shared papers)James E. Stefano (5 shared papers)Robert J. Miller (5 shared papers)Anna Park (2 shared papers)William Brondyk (3 shared papers)Pradeep K. Dhal (1 shared paper)Clark Q. Pan (1 shared paper)Bo Chen (1 shared paper)
- Journals
- Bioconjugate Chemistry (3 papers)Biotechnology and Bioengineering (1 paper)Organic & Biomolecular Chemistry (1 paper)ChemMedChem (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Michelle Busch
8 papers receiving 260 citations
Peers
Comparison fields: 5 of 40
- Radiology, Nuclear Medicine and Imaging 185
- Oncology 147
- Organic Chemistry 69
- Molecular Biology 137
- Biotechnology 11
Countries citing papers authored by Michelle Busch
This map shows the geographic impact of Michelle Busch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Busch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Busch more than expected).
Fields of papers citing papers by Michelle Busch
This network shows the impact of papers produced by Michelle Busch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Busch. The network helps show where Michelle Busch may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle Busch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 181 | |
| 2 | 2012 | 28 | |
| 3 | 2012 | 19 | |
| 4 | 2019 | 14 | |
| 5 | 2013 | 13 | |
| 6 | 2018 | 12 | |
| 7 | 2013 | 10 | |
| 8 | 2013 | 3 |
About Michelle Busch
Michelle Busch is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Biomaterials and Infectious Diseases, having authored 8 papers that have together received 280 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (5 papers), Glycosylation and Glycoproteins Research (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Cell Adhesion Molecules Research (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Viral gastroenteritis research and epidemiology (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (185 citations), Oncology (147 citations), Organic Chemistry (69 citations), Molecular Biology (137 citations) and Biotechnology (11 citations). Michelle Busch has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Diego A. Gianolio, James E. Stefano, Robert J. Miller, Anna Park, William Brondyk, Pradeep K. Dhal, Clark Q. Pan, Bo Chen, Julie Bird and Jennifer Kim. Their work appears in journals such as Bioconjugate Chemistry, Biotechnology and Bioengineering, Organic & Biomolecular Chemistry, ChemMedChem and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.